NEW YORK (GenomeWeb) – Invitae reported Thursday after the close of the market that its sales increased seven-fold year over year for the third quarter.

For the three months ended Sept. 30, the firm reported revenues of $2.2 million, up from $310,000 for Q3 2014 but short of the consensus Wall Street estimate of $2.6 million.

The company billed more than 5,100 reports during the third quarter, a 360 percent increase compared to the year ago period, and accessioned more than 5,400 samples.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.